What the extra cash for cancer drugs in the UK really means
This article was originally published in Scrip
Executive Summary
At first sight, the recent announcement in the UK that £50 million is to be made available as an interim measure to fund the supply of expensive new cancer drugs (scripintelligence.com, 28 July 2010), sounds like good news.